During the past decade, Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 24 trials, followed by "Fondazione Italiana Linfomi ONLUS" with 4 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored, "Janssen-Cilag Ltd." with 1 trials sponsored and "Janssen-Cilag S.p.A." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto" #1 collaborator was "CML Advocates Network" with 1 trials as a collaborator, "European Leukemia Net" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator, "Hematology Project Foundation" with 1 trials as a collaborator and "Legend Biotech" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto" are "Leukemia" (3 trials), "Acute Myeloid Leukemia" (2 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Chronic Myeloid Leukemia" (2 trials) and "Multiple Myeloma" (2 trials). Many other conditions were trialed in "Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto" in a lesser frequency.

Most popular intervention types in "Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto" are "Drug" (19 trials), "Other" (10 trials), "Procedure" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Imatinib" (2 trials), "Nilotinib" (2 trials), "Observation" (2 trials), "Rituximab" (2 trials) and "Venetoclax" (2 trials). Other intervention names were less common.

The vast majority of trials in "Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto" are 31 trials for "All" genders.

Currently, there are NaN active trials in "Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto". 1 are not yet recruiting, 13 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".